You are not currently logged in.
Access JSTOR through your library or other institution:
Human Herpesvirus 6
Mary T. Caserta, David J. Mock and Stephen Dewhurst
Clinical Infectious Diseases
Vol. 33, No. 6 (Sep. 15, 2001), pp. 829-833
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4461706
Page Count: 5
Preview not available
The development of techniques for the culture of lymphoid cells and the isolation of viruses that infect these cells led to the discovery of human herpesvirus (HHV) 6 in 1986. At the time, HHV-6 was the first new human herpesvirus to be discovered in roughly a quarter of a century, and its isolation marked the beginning of an era of discovery in herpesvirology, with the identification of HHV-7 and HHV-8 (Kaposi's sarcoma-associated herpesvirus) during the following decade. Like most human herpesviruses, HHV-6 is ubiquitous and capable of establishing a lifelong, latent infection of its host. HHV-6 is particularly efficient at infecting infants and young children, and primary infection with the virus is associated with roseola infantum (exanthem subitum) and, most commonly, an undifferentiated febrile illness. Viral reactivation in the immunocompromised host has been linked to a variety of diseases, including encephalitis, and HHV-6 has been tentatively associated with multiple sclerosis. This article discusses the major properties of HHV-6, its association with human disease, and the pathobiological significance of viral reactivation.
Clinical Infectious Diseases © 2001 Oxford University Press